MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 103 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,621,118 | $38,939,254 | 45.05% |
| NEA Management Company, LLC | 4,186,243 | $100,553,557 | 6.95% |
| Frazier Life Sciences Management, L.P. | 3,860,107 | $92,719,770 | 6.71% |
| Prosight Management, LP | 567,826 | $13,639,181 | 6.47% |
| TANG CAPITAL MANAGEMENT LLC | 1,170,000 | $28,103,400 | 4.19% |
| Highlander Partners, L.P. | 122,980 | $2,953,980 | 4.00% |
| Novo Holdings A/S | 1,684,193 | $40,454,316 | 2.67% |
| CADIAN CAPITAL MANAGEMENT, LP | 734,922 | $17,652,826 | 1.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,032,335 | $48,816,687 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,939 | $2,544,655 | 1.05% |